Cochrane · systematic review · CD007953

Intermittent versus daily therapy for treating tuberculosis in children

Bose, A, Kalita, S, Rose, W, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library

Infectious DiseasesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Intermittent short‐course anti‐TB regimens compared to daily anti‐TB regimens for treating TB in children

Population: Children with TB1
5 questions
OutcomeEffectEvidenceStatus / GRADE
Cure
Intermittent short‐course anti‐TB regimens vs daily anti‐TB regimens
RR 1.01 [0.94, 1.1]4 studies · 465 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Death from any cause
Intermittent short‐course anti‐TB regimens vs daily anti‐TB regimens
RR 1.52 [0.26, 8.96]2 studies · 213 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Relapse
Intermittent short‐course anti‐TB regimens vs daily anti‐TB regimens
RR 3.68 [0.15, 89.33]1 study · 214 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness
Adherence to treatment
Intermittent short‐course anti‐TB regimens vs daily anti‐TB regimens
RR 1.04 [0.97, 1.11]4 studies · 458 participantsVery low
Downgraded: inconsistency, indirectness
Treatment‐limiting adverse events
Intermittent short‐course anti‐TB regimens vs daily anti‐TB regimens
RR 0.4 [0.06, 2.6]4 studies · 441 participantsVery low
Downgraded: risk of bias, inconsistency, indirectness